机译:欧洲和美国过敏原免疫疗法的过敏原制造和质量方面:eAaci AIT EAACI AIT指南项目的分析
Paul‐Ehrlich‐InstitutLangen Germany;
University of SouthamptonSouthampton UK;
US Food and Drug AdministrationSilver Spring MD USA;
US Food and Drug AdministrationSilver Spring MD USA;
US Food and Drug AdministrationSilver Spring MD USA;
CBG‐MEB (Medicines Evaluation Board)Utrecht The Netherlands;
Division of Biological ProductsAgencia Espa?ola de Medicamentos y Productos Sanitarios (AEMPS;
Istituto Superiore di SanitàRome Italy;
Department of Otorhinolaryngology Head and Neck SurgeryUniversit?tsmedizin MannheimMannheim Germany;
The University of EdinburghScotland UK;
Usher Institute of Population Health Sciences and InformaticsUniversity of Edinburgh Medical;
Swiss Institute of Allergy and Asthma ResearchUniversity ZurichDavos Switzerland;
Division of Allergy Immunology and TransplantationNational Institute of Allergy and Infectious;
Allergy ClinicCopenhagen University Hospital at GentofteCopenhagen Denmark;
Departments of Experimental Immunology and of OtorhinolaryngologyUniversity of AmsterdamAmsterdam;
Swiss Institute of Allergy and Asthma ResearchUniversity ZurichDavos Switzerland;
Universidad CEU San PabloMadrid Spain;
Department of Biochemistry and Molecular BiologyComplutense University of Madrid (UCM)Madrid Spain;
Nippon Medical SchoolTokyo Japan;
Patient advocacy GroupDutch Lung FoundationAmersfoort The Netherlands;
Center for Rhinology and AllergologyWiesbaden Germany;
Faculty of MedicineTransylvania University BrasovBrasov Romania;
Sheffield Teaching HospitalSheffield UK;
University of South FloridaTampa FL USA;
Allergy DepartmentHospital Clinico San Carlos IdISSCMadrid Spain;
Hans Christian Andersen Childrens HospitalOdense University HospitalOdense Denmark;
Wroclaw Medical UniversityDepartment of Clinical ImmunologyWroclaw Poland;
Department for Pediatric Pneumology and ImmunologyCharité Universit?tsmedizinBerlin Germany;
Department of Pediatrics and Allergy UnitUniversity of MessinaMessina Italy;
Department of Dermatology and VenerologyMedical University of GrazGraz Austria;
Medical University of GrazGraz Austria;
Erasmus MCRotterdam The Netherlands;
University of Campania Luigi VanvitelliIFT‐CNRNaples and Rome Italy;
Padua University HospitalPadua Italy;
Paul‐Ehrlich‐InstitutLangen Germany;
allergen immunotherapy; allergy; manufacturing; quality; regulation;
机译:欧洲和美国过敏原免疫疗法的过敏原制造和质量方面:eAaci AIT EAACI AIT指南项目的分析
机译:EAACI EAACI对过敏原指南实施的挑战:全球对过敏原产品调节的视角
机译:EAACI EAACI对过敏原免疫疗法指南:IgE介导的食物过敏
机译:确保整个欧洲的室内空气质量(IAQ):制定基于健康的通风指南(HealthVent项目)
机译:在大湖区区域内,欧洲落叶松(Larix decidua Miller)和赤松(Pinus resinosa Ait。)的生产力和相关性状的比较。
机译:过敏原免疫治疗呼吸道过敏:使用现实生活证据评估工具的观测比较有效性研究的质量评估。 EACI方法委员会分析
机译:EAACI AIT指南实施中的挑战:过敏原免疫治疗当前现状的情况分析
机译:制造技术项目成本节约分析指南